Galacto-Oligosaccharide Market

How big is Galacto-Oligosaccharide Market in 2026?

Demand for galacto-oligosaccharide is projected to expand at 6.7% CAGR between 2026 and 2036. Industry value grows from USD 1,058.9 million in 2025 to USD 1,129.9 million in 2026 and is projected to reach USD 2,151.4 million by 2036.

Increasing use of galacto-oligosaccharide in infant nutrition, dairy products, supplements and medical nutrition is driving the market at a rapid pace. The market is valued at USD 1,129.9 million in 2026, up from USD 1,058.9 million in 2025, and is expected to reach USD 2,151.4 million by 2036. In April 2025, FrieslandCampina Ingredients announced 16 accepted FSANZ health claims for Biotis GOS, Vivinal GOS and Biotis Fermentis[1]. This is expected to support their use in Australia and New Zealand. Increasing demand for prebiotic products and development of adult nutrition formats are also expected to support galacto-oligosaccharide market. The prebiotic ingredient market is similarly growing due to increasing use of ingredients with proven formulation performance and permitted health claims.

Regional expansion dynamics diverge across leading markets as regulatory clearance pathways and dietary patterns shape commercial uptake. Increasing focus on digestive health and rising demand for functional food products is expected to create growth opportunities across Japan and the USA. Japan is projected to grow at 8.6% CAGR through 2036, while the USA is expected to expand at 7.6% CAGR. A May 2026 CDC brief reported that 60.2% of US adults used dietary supplements, supporting demand for digestive and immune health ingredients[2]. Japan has an established functional food review system, whereas buyers in the USA mainly assess the ingredient record and its intended use. Similar conditions are witnessed in the prebiotic fiber market, where local claim rules and performance in the final product influence adoption.

Key Takeaways of Galacto-Oligosaccharide Market

• Demand for galacto-oligosaccharide is increasing as manufacturers select grades according to recipe, permitted use, processing condition and supplier records.
• Based on form, Liquid is expected to account for 60.7% in 2026, owing to its easy dosing in wet processing lines.
• By application, Food and Beverage is estimated to hold 79.7% in 2026 due to established use in dairy and nutrition products.
• Japan is projected to grow at 8.6% CAGR, while the USA is expected to expand at 7.6% through 2036.
• Notable companies include Royal FrieslandCampina N.V., Vitalus Nutrition Inc., Ingredion Incorporated, Yakult Honsha Co., Ltd., and Clasado Ltd.

Analyst Perspective

“Increasing use in adult nutrition is reducing dependence on infant formula; however, every grade still requires evidence for its dose, final format and local claim route.”

- Nandini Roy Choudhury, Principal Consultant, Future Market Insights.

How is the Galacto-Oligosaccharide Market segmented?

Galacto-oligosaccharide market is segmented by form, application, and region. Liquid is projected at 60.7%, while food and beverage is forecast at 79.7% in 2026.

• By form: Liquid and Powder.
• By application: Food and Beverage, Pharma and Personal Care, and Animal Feed.
• By region: North America, Latin America, Western Europe, Eastern Europe, East Asia, South Asia and Pacific, and Middle East and Africa.

Why does liquid hold a notable share of form demand?

Based on form, liquid is projected to account for 60.7% in 2026, supported by direct dosing in wet processing lines.

Liquid galacto-oligosaccharide can be directly added into dairy and beverage systems without a separate powder dissolving stage. Syrup grades are supplied with defined solids, viscosity and microbiological limits, which supports repeatable processing. Liquid form is mainly preferred by plants that already use wet ingredients, while Powder is used in dry blends and compact nutrition products. The functional food ingredients market is also witnessing demand for formats that reduce handling steps and maintain dosing accuracy.

• Liquid is projected to hold 60.7% in 2026, as the syrup can be added through controlled dosing in existing wet processing lines.
• In September 2026, FrieslandCampina Ingredients reported that GOS is present in around half of infant formulations across the globe, which reflects its established formulation base[3].

What supports food and beverage as the preferred application?

By application, food and beverage is estimated to hold 79.7% in 2026, owing to established dairy and nutrition use.

Food and Beverage is expected to remain the leading application as galacto-oligosaccharide is used in infant formula, dairy products, beverages, bakery products and functional foods. The dose and label requirement may differ in every product, which makes application testing important. Increasing sales of functional food and nutrition products are expected to support the segment. The dietary fibers and prebiotic fiber market also displays similar demand, as sensory performance and declared dose are important in the final product.

• Food and Beverage is estimated to account for 79.7% in 2026, owing to wider use of approved galacto-oligosaccharide grades across formulated products.
• In August 2025, Clasado reported a measurable bifidogenic effect from 380 milligrams of active Bimuno GOS per day, which supports its use in capsules and other compact formats[4].

What are the drivers, restraints, and opportunities in the Galacto-Oligosaccharide Market?

The key driver is wider accepted use, the key restraint is product-specific requalification, and the main opportunity is adult nutrition.

• Driver: Increasing number of accepted uses is supporting the addition of galacto-oligosaccharide into regular food and nutrition recipes.
• Restraint: Product-specific evidence and claim requirements increase the time and cost involved in changing a supplier or grade.
• Opportunity: Increasing demand for adult supplements, sports nutrition and medical nutrition is creating opportunities beyond infant-focused applications.

Accepted Uses Support Recipe Adoption

Increasing number of accepted uses is one of the prominent factors driving the galacto-oligosaccharide market. A grade is generally purchased for a defined final product and dose. FDA GRAS Notice 1216 listed use levels from 0.62 grams to 40 grams per 100 grams across several food categories, although the evaluation ceased at the notifier’s request in April 2025[5]. This indicates that intended use, dose and target population need to be properly documented. The precision prebiotic blends market is also expected to grow with increasing demand for ingredients supported by application-specific formulation records.

Requalification Slows Supplier Changes

Changing a galacto-oligosaccharide supplier can require composition checks, stability testing and label review, which can hinder quick adoption of a new grade. In August 2025, South Korea’s imported-food system recorded lactose-derived galacto-oligosaccharides with ingredient identity and manufacturing route[6]. Batch identity and supporting records therefore remain important for market access. Lower prices alone may not encourage a change when manufacturers have to repeat technical and regulatory checks.

Adult Nutrition Broadens Addressable Use

Increasing demand for adult supplements and sports nutrition is expected to broaden the application of galacto-oligosaccharide beyond infant formula. In March 2026, a six-week athlete study reported 38% reduction in the pre-post change in I-FABP and shorter upper-respiratory symptom episodes in the Bimuno GOS group[7]. Such developments are expected to support its use in performance nutrition products, where low dose and application stability are important. This opportunity is also visible across the gut health supplements market.

Which country CAGRs are profiled in the Galacto-Oligosaccharide Market?

Country	CAGR
Japan	8.6%
USA	7.6%
Germany	6.7%
South Korea	5.5%
UK	5.1%

How do country-level CAGRs compare in the galacto-oligosaccharide market?

Country demand follows functional food regulations, dietary guidelines, and the presence of approved infant nutrition and adult food processing lines. Japan leads growth with an established functional claims framework, while the USA provides a vast market for formulated dietary supplements and fortified foods. In Germany and the UK, demographic shifts toward an aging population are elevating adult functional nutrition alongside early-life products. In South Korea, formal imported-food review standards guide ingredient compliance.

• Japan combines established functional food regulations (FOSHU and Foods with Function Claims) with widespread consumer familiarity.
• USA demand spans infant nutrition, fortified dairy, and a large consumer base for dietary supplements.
• Germany balances infant formula standards with expanding demand for adult nutrition and clinical formulations.
• South Korea enforces formal import clearance codes and rigorous product identity checks for functional ingredients.
• UK emphasizes adult functional foods and supplements as formulation standards adapt to changing demographic profiles.

Full report country CAGRs cover: North America; Latin America; Western Europe; Eastern Europe; East Asia; South Asia and Pacific; Middle East and Africa.

Country-wise Analysis

• By 2036, Japan is projected to grow at 8.6% CAGR, owing to established demand for functional food products. Japan’s food labeling system includes Foods for Specified Health Uses, Foods with Nutrient Function Claims and Foods with Function Claims. A 2026 Consumer Affairs Agency guide confirms that these routes follow government standards for safety and effectiveness[8]. This established structure is expected to support galacto-oligosaccharide products with suitable evidence and labeling. Suppliers are also focusing on composition records and application-specific support.
• Over the forecast period, the USA is expected to grow at 7.6% CAGR, supported by increasing use in infant nutrition, dairy products and functional foods. The NIH Dietary Supplement Label Database contained more than 214,000 labels during 2026, reflecting the large formulation base for digestive health and prebiotic products[9]. Wider application is expected to support demand; however, every ingredient record remains connected with defined conditions of use and maximum levels.
• Germany is projected to grow at 6.7% CAGR during the forecast period. Germany recorded 654,241 births in 2025, while total fertility rate declined by 2.7% to 1.32 children per woman[10]. Declining births can limit growth from infant-focused products; however, increasing use in adult food, supplements and medical nutrition is expected to create new growth avenues. Established early-life nutrition applications will continue to support demand under regulated conditions.
• South Korea is expected to grow at 5.5% CAGR through 2036, owing to increasing demand for functional food ingredients. South Korea’s imported-food portal records ingredient codes and requires users to check the applicable food and additive standards before use[11]. This formal import process is expected to benefit suppliers that maintain consistent product identity, shipment records and final application documents.
• The UK is projected to grow at 5.1% CAGR from 2026 to 2036. England and Wales recorded 585,396 live births in 2025, down 1.6% from 2024, while total fertility rate declined to 1.39[12]. The smaller infant population is increasing the importance of adult functional foods and supplements for future demand. Lawful claims and stable performance in the finished product will remain important for adoption.

Who are the notable companies in the Galacto-Oligosaccharide Market?

Royal FrieslandCampina N.V., Van Wankum Ingredients, King-Prebiotics Biotech Co., Ltd., Vitalus Nutrition Inc., Novonesis A/S, Ingredion Incorporated, Kerry Group plc, Yakult Honsha Co., Ltd., Clasado Ltd., and Nissin Sugar Co., Ltd. are notable companies.

The galacto-oligosaccharide market includes direct ingredient manufacturers, specialist prebiotic companies and process technology providers. Direct suppliers are focusing on grade format, composition records and application support, while specialist companies offer concentrated products for defined nutrition uses. Process and enzyme companies influence how and where galacto-oligosaccharide can be manufactured. Buyers generally compare product specification, evidence, supply continuity and local technical support before selecting a supplier.

• Direct GOS portfolios: Royal FrieslandCampina N.V., Vitalus Nutrition Inc., Ingredion Incorporated, Yakult Honsha Co., Ltd., and Nissin Sugar Co., Ltd.
• Specialist prebiotic suppliers: Van Wankum Ingredients, King-Prebiotics Biotech Co., Ltd., and Clasado Ltd.
• Process and enzyme platforms: Novonesis A/S and Kerry Group plc.

Competitive Benchmarking: Galacto-Oligosaccharide Market

Company	Purity / Grade Breadth	Application Support	Regulatory Evidence	Geographic Reach
Royal FrieslandCampina N.V.	High	High	High	High
Vitalus Nutrition Inc.	High	Medium	High	High
Ingredion Incorporated	High	High	High	High
Yakult Honsha Co., Ltd.	High	Medium	High	Medium
Clasado Ltd.	High	High	High	High
Van Wankum Ingredients	Medium	Medium	Medium	High
King-Prebiotics Biotech Co., Ltd.	High	Medium	Medium	Medium
Novonesis A/S	High	High	High	High
Kerry Group plc	High	High	High	High
Nissin Sugar Co., Ltd.	Medium	Medium	High	Medium

Key Developments in the Galacto-Oligosaccharide Market

• In February 2026, Clasado reported that Bimuno GOS had crossed 130 published studies and 25 clinical studies. The expanded clinical validation supports broader inclusion in formulated digestive wellness and immune health products.
• In April 2025, FrieslandCampina Ingredients announced 16 accepted FSANZ health claims for Biotis GOS, Vivinal GOS and Biotis Fermentis. The regulatory milestone facilitates compliant on-pack claims for food and infant nutrition manufacturers in Australia and New Zealand.
• In April 2025, Clasado sold its Bimuno consumer supplement range to ELEAT and retained the B2B galacto-oligosaccharide ingredient business. The divestment enables dedicated focus on core ingredient innovation, bulk synthesis, and B2B client formulation partnerships.

Key Players in the Galacto-Oligosaccharide Market

Direct Galacto-Oligosaccharide Manufacturers

• Royal FrieslandCampina N.V.
• Vitalus Nutrition Inc.
• Ingredion Incorporated
• Yakult Honsha Co., Ltd.
• Nissin Sugar Co., Ltd.

Specialist Prebiotic Suppliers

• Van Wankum Ingredients
• King-Prebiotics Biotech Co., Ltd.
• Clasado Ltd.

Process Technology and Enzyme Platforms

• Novonesis A/S
• Kerry Group plc

Galacto-Oligosaccharide Market - Report Scope

Coverage field	Report scope
Market breakdown	Form; Application; Region.
Quantitative units	USD million.
Market definition	Revenue from GOS ingredients sold in liquid or powder form. Finished-product revenue and adjacent prebiotics are excluded.
Regions covered	North America; Latin America; Western Europe; Eastern Europe; East Asia; South Asia and Pacific; Middle East and Africa.
Countries covered	Japan, USA, Germany, South Korea, UK, and additional countries in the full report.
Key companies profiled	Royal FrieslandCampina N.V., Van Wankum Ingredients, King-Prebiotics Biotech Co., Ltd., Vitalus Nutrition Inc., Novonesis A/S, Ingredion Incorporated, Kerry Group plc, Yakult Honsha Co., Ltd., Clasado Ltd., and Nissin Sugar Co., Ltd.
Forecast period	2026 to 2036.
Approach	The Future Market Insights report covers ingredient-level demand, formulation trends, segment structure, and country adoption conditions.

Galacto-Oligosaccharide Market - Research Methodology

Method	Approach
Primary Research	The research study includes primary interviews with manufacturers, food and beverage brand owners, distributors, procurement managers, and nutrition experts. Interviews cover purchasing criteria, dosage requirements, pricing, and regulatory validation.
Desk Research	Desk research includes government food agency publications, monograph standards, scientific literature, company filings, and official announcements. Sources were verified according to date, jurisdiction, and technical relevance.
Market Sizing and Forecasting	Market sizing combines base ingredient volume and pricing with historical growth, application adoption, supplier capacity, and regional demand. Forecast models integrate infant formula demographics, adult nutrition trends, and health claim approvals.
Data Validation	Market estimates were cross-checked against public disclosures, import-export records, trade announcements, and primary interview insights. Downstream consumer product revenues and non-GOS prebiotic fibers were excluded.

Galacto-Oligosaccharide Market by Segments

Galacto-Oligosaccharide Market segmented by Form:

• Liquid
• Powder

Galacto-Oligosaccharide Market segmented by Application:

• Food and Beverage
• Pharma and Personal Care
• Animal Feed

Galacto-Oligosaccharide Market by Region

• North America
  • United States
  • Canada
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Chile
• Western Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Benelux
  • Nordics
• Eastern Europe
  • Poland
  • Czech Republic
  • Romania
  • Hungary
• East Asia
  • China
  • Japan
  • South Korea
• South Asia and Pacific
  • India
  • ASEAN
  • Australia and New Zealand
• Middle East and Africa
  • GCC Countries
  • South Africa
  • Türkiye
  • Israel

Research Sources and Bibliography

• [1] FrieslandCampina Ingredients. (2025, April 3). FrieslandCampina Ingredients achieves 16 new FSANZ health claims for Biotis GOS, Vivinal GOS and Biotis Fermentis.
• [2]National Center for Health Statistics. (2026, May 21). Dietary supplement use: United States, August 2021-August 2023.
• [3] FrieslandCampina Ingredients. (2026, September 14). Galacto-oligosaccharides prebiotics in infant milk formula: From ingredient to application.
• [4] Clasado Biosciences. (2025, August 26). Bimuno GOS delivers prebiotic effect at an ultra-low dose.
• [5]U.S. Food and Drug Administration. (2025, April 10). GRAS Notice No. 1216: Galacto-oligosaccharides.
• [6] Ministry of Food and Drug Safety, South Korea. (2025, August 22). Imported food record: Galacto-oligosaccharides.
• [7] Clasado Biosciences. (2026, March 30). Bimuno GOS supports gut barrier integrity and immune health in athletes.
• [8]Consumer Affairs Agency, Japan. (2026). For informed food choices.
• [9]National Institutes of Health, Office of Dietary Supplements. (2026). Dietary Supplement Label Database.
• [10]Statistisches Bundesamt. (2026, July 1). Total fertility rate drops to 1.32 children per woman in 2025.
• [11] Ministry of Food and Drug Safety, South Korea. (2026). Ingredient code and imported-food standards portal.
• [12]Office for National Statistics. (2026, September 8). Births in England and Wales: 2025 final rates.

This bibliography is provided for reader reference. The full report contains the complete reference list and detailed citations.

This Report Answers

• What is the galacto-oligosaccharide market worth during 2026?
• What value is the galacto-oligosaccharide market projected by 2036?
• Which form holds notable galacto-oligosaccharide market share in 2026?
• Which application holds notable galacto-oligosaccharide market share in 2026?
• Which country has a notable galacto-oligosaccharide growth outlook?
• Which companies are notable in the galacto-oligosaccharide market today?